HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
Asia Biotech Live
LATEST UPDATES » Vol 24, No 01, January 2020 – Empowering the Patient - Personalization of Diabetes Management       » First of its kind Human Heart-in-a-Jar Model for therapeutic solutions       » China's National Vaccine Tracking System set to be completed in 2020       » China's amended drug administration law kicks in       » Human activity puts Chinese plant biodiversity at risk, study finds       » Contributory effects of each brain cell type in development of Alzheimer's Disease      
Vol 23, No. 11, November 2019For e-subscribers (PDF)
EYE ON CHINA
Researchers Try "One-Two Punch" Method to Treat Liver Cancer
An international team of researchers have found a "one-two punch" method to treat liver cancer by inducing weakness in liver cancer cells and exploiting the vulnerability to reduce tumour growth.

Researchers from Shanghai Jiao Tong University's School of Medicine and the Netherlands Cancer Institute found they can selectively induce senescence in liver cancer cells with mutations in a gene named TP53.

Senescence means the loss of a cell's power of division and growth, similar to putting the cell into a sleep mode.

The researchers said that the cells in the sleep mode have an "acquired vulnerability" and a follow-up screening will select a suitable chemical agent to target the vulnerability and kill cancer cells.

They said the two-step treatment is like the classic "one-two punch" from boxing. A combination of two blows is delivered in rapid succession: a left jab to expose the cancer cell's weak points quickly followed by a right cross to knock them out.

Meanwhile, the treatment has minimal side effects on other cells in normal proliferation, they added.

According to the research published in the journal Nature early this month, the treatment resulted in a marked reduction of tumor growth in mouse models of liver cancer.

The researchers said their study indicates that exploiting an induced vulnerability could be an effective treatment for liver cancer.

Liver cancer is a common malignant tumor with poor prognosis. Surgery and liver transplants so far are the most effective treatments. However, due to the difficulty of early diagnosis and rapid progression of the disease, most patients are unable to undergo surgery when they are diagnosed.

(Source: Xinhua)

Click here for the complete issue.

NEWS CRUNCH  
news Joining Forces to Elevate Asia's Healthcare Industry
news 4th Global Feed Summit draws Feed Producers, Technology Providers, Raw Materials Suppliers to Bangkok for Key Discussions
news 2nd China Pharma Digital Innovation Summit to be held in Shanghai
news 2nd China Healthcare Digital Innovation Summit to be held in Shanghai
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy